Dr. Reddy's Laboratories Limited
DRREDDY
주식 순위
#1921
Established in 1984 and headquartered in Hyderabad, India, Dr. Reddy's... Established in 1984 and headquartered in Hyderabad, India, Dr. Reddy's Laboratories Limited functions as a fully integrated global pharmaceutical entity. Its business is structured into several core divisions. The Global Generics segment is responsible for the production and distribution of prescription and over-the-counter finished pharmaceutical products, marketed either under their own brand names or as generic versions therapeutically equivalent to branded formulations, also encompassing biologics. The Pharmaceutical Services and Active Ingredients (PSAI) division manufactures and supplies active pharmaceutical ingredients (APIs) and intermediates, which are fundamental components for finished drugs, alongside offering contract research services and custom production of APIs and steroids. The Proprietary Products segment is dedicated to the research and development of unique and differentiated drug formulations. Furthermore, its "Others" segment focuses on developing treatments for oncology and inflammatory conditions. The company's therapeutic reach spans numerous areas including gastro-intestinal, cardiovascular, anti-diabetic, dermatological, oncology, respiratory, stomatological, urological, and nephrological health. Dr. Reddy's also maintains a strategic collaboration with Curis, Inc., centered on the discovery, development, and commercialization of small molecule antagonists for immuno-oncology and precision oncology applications.
주가
$13.01
시가총액
$10.83B
변동 (1일)
-4.90%
변동 (1년)
-11.16%
국가
IN
거래 Dr. Reddy's Laboratories Limited (DRREDDY)
카테고리
Healthcare
Dr. Reddy's Laboratories Limited (DRREDDY)의 매출
Oct 2026 기준 매출 TTM: 0
Dr. Reddy's Laboratories Limited의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Dr. Reddy's Laboratories Limited의 수익 기록 (2001 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2008 | $1.25B | -16.98% |
| 2007 | $1.51B | 175.55% |
| 2006 | $546.26M | 22.50% |
| 2005 | $445.93M | -3.81% |
| 2004 | $463.60M | 22.55% |
| 2003 | $378.29M | 11.12% |
| 2002 | $340.43M | 44.70% |
| 2001 | $235.27M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
